Sort by
Refine Your Search
-
and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research
-
the form and share it with your letter writers. Recommendations must be submitted directly by the recommender and cannot be submitted by the applicant. Address cover letter and letters of recommendation
-
experience in integrated evidence generation plan (IEGP) development, RWE generation, HEOR strategy and analytics, health technology assessment, value dossier development, and payer engagement. Year 2 consists
-
, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of
-
has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex
-
, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of
-
therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust
-
fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of
-
. About GSK GSK is a focused biopharma company with strong momentum and big ambitions, to unite science, technology, and talent to get ahead of disease together. We aim to positively impact the health
-
programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology